Browser-side verification
Verify Methimazole
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "methimazole",
"nameEn": "Methimazole",
"nameTh": "เมไทมาโซล",
"class": "Antithyroid — thyroid peroxidase inhibitor (feline hyperthyroidism)",
"mechanism": "ยับยั้งเอนไซม์ thyroid peroxidase ขัดขวางการสร้างฮอร์โมนไทรอยด์ (T4/T3); ควบคุมแต่ไม่รักษาให้หาย จึงต้องให้ต่อเนื่อง; เป็นยาหลักของ feline hyperthyroidism",
"brandNamesTh": [
"Tapazole",
"Felimazole"
],
"indications": [
{
"text": "ภาวะไทรอยด์เป็นพิษในแมว (feline hyperthyroidism) — ควบคุมระดับฮอร์โมน; ใช้ก่อนผ่าตัด/รังสีบำบัด หรือเป็นการรักษาระยะยาว; มีรูปแบบ transdermal สำหรับแมวที่ป้อนยาก",
"cites": [
"merck-thyroid",
"todaysvetpractice"
]
}
],
"contraindications": [
{
"text": "ระวังในแมวที่มีโรคไตซ่อนเร้น (การลดไทรอยด์อาจเผยภาวะไตวาย); ตรวจ CBC เพราะอาจกด bone marrow",
"cites": [
"merck-thyroid"
]
}
],
"sideEffects": [
{
"text": "เบื่ออาหาร อาเจียน ซึม (ช่วงแรก), อาการคันที่หน้า (facial excoriation), ตับอักเสบ, เม็ดเลือดต่ำ (blood dyscrasia); เผยภาวะไตวายที่ซ่อนอยู่",
"cites": [
"merck-thyroid"
]
}
],
"dosages": [
{
"species": "feline",
"indication": "Hyperthyroidism",
"route": "PO",
"dose": "2.5 mg/ตัว ทุก 12 ชั่วโมง (เริ่มต้น 2 สัปดาห์) แล้วปรับตามระดับ T4; ส่วนใหญ่ต้องการ 5–7.5 mg/วัน",
"cites": [
"merck-thyroid",
"todaysvetpractice"
]
}
],
"citations": [
{
"id": "merck-thyroid",
"type": "textbook",
"title": "Thyroid disease (hypo/hyperthyroidism) — MSD/Merck Veterinary Manual",
"year": 2025,
"url": "https://www.merckvetmanual.com/endocrine-system/the-thyroid-gland/hyperthyroidism-in-animals",
"note": "Merck endocrine reference — methimazole + levothyroxine dosing. Copyrighted, cited not mirrored.",
"cid": null
},
{
"id": "todaysvetpractice",
"type": "guideline",
"title": "Today's Veterinary Practice — clinical pharmacology reviews",
"year": 2024,
"url": "https://todaysveterinarypractice.com/",
"note": "Peer-reviewed veterinary clinical practice journal — methimazole, cyclosporine, epilepsy dosing reviews.",
"cid": null
},
{
"id": "dailymed-methimazole",
"type": "regulatory-database",
"title": "Methimazole — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=methimazole",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "7806ca0e56fae0933b6502565c9f094e6b09ffa955aa272862c690aa81680f8f"
},
{
"id": "atc-H03BB02",
"type": "guideline",
"title": "ATC H03BB02 — Thiamazole (Methimazole)",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=H03BB02&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "b3492b960812fa2bf4aeabf5608c0b230461eed305bca31ac8da4fc304b691cb"
},
{
"id": "pubchem-methimazole",
"type": "monograph",
"title": "Methimazole — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Methimazole",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "7603b5d778c96b682ba80bddf41ae78b729508dd26dba0b729e6bddb72ca25bf"
},
{
"id": "who-eml-22",
"type": "guideline",
"title": "WHO Model List of Essential Medicines (22nd List, 2021)",
"year": 2021,
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"note": "Cross-checked source: drug appears on WHO EML — WHO recognizes its place in basic healthcare.",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=methimazole",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=H03BB02&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Methimazole",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "who-eml",
"name": "WHO Model List of Essential Medicines (22nd List, 2021)",
"url": "https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02",
"asOfDate": "2026-05-27",
"license": "CC BY-NC-SA 3.0 IGO"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "7806ca0e56fae0933b6502565c9f094e6b09ffa955aa272862c690aa81680f8f",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "b3492b960812fa2bf4aeabf5608c0b230461eed305bca31ac8da4fc304b691cb",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "7603b5d778c96b682ba80bddf41ae78b729508dd26dba0b729e6bddb72ca25bf",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "who-eml",
"cid": "71030c795c4e0c0cff56566bfc9ae4ed448eab9188ae68ce773a50d9f7fc53eb",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "H03BB02",
"name": "Thiamazole (Methimazole)",
"level": 5
},
"rxnorm": {
"cui": "6835",
"name": "Methimazole"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WHO Model List of Essential Medicines (22nd List, 2021)). ATC H03BB02 + RxNorm 6835. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — methimazole 2.5 mg/cat q12h start + T4/renal monitoring verified against Merck thyroid + Today's Veterinary Practice. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
],
"monitoring": [
{
"text": "ตรวจ total T4, CBC, และค่าไต (BUN/creatinine) ที่ 2–3 สัปดาห์หลังเริ่มและทุกครั้งที่ปรับขนาด",
"cites": [
"merck-thyroid"
]
}
]
}Public keys used
[]